In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma
By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
Copyright © 2014-2022 - AIM en la Fundación del Melanoma. Todos los derechos reservados. Sitio web por RED ZEPHYR DESIGN